Endothelial dysfunction and aging: An update

Ageing Research Reviews

Volumn 9, Issue 2, 2010, Pages 142-152

  Herrera, María Dolores ^a   Mingorance, Carmen ^a   Rodríguez Rodríguez, Rosalía ^a   Alvarez de Sotomayor, Maria ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Age related oxidative stress; Aging; Endothelial dysfunction; Nitric oxide; Senescence of endothelial cells; Vascular inflammation

Indexed keywords

ARGINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; KLOTHO PROTEIN; NEURONAL NITRIC OXIDE SYNTHASE; TETRAHYDROBIOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

AGING; CELL REGENERATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SYNTHESIS; HEREDITY; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SENESCENCE; VASCULAR ENDOTHELIUM;

AGING; ANIMALS; CARDIOVASCULAR DISEASES; CELL AGING; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; NITRIC OXIDE; OXIDATIVE STRESS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; VASOCONSTRICTION; VASODILATION;

EID: 77949266553     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2009.07.002     Document Type: Review

References (150)

1. Adachi T., Wang J., and Wang X.L. Age-related change of plasma extracellular-superoxide dismutase. Clin. Chim. Acta 290 (2000) 169-178
2. Al-Shaer M.H., Choueiri N.E., Correia M.L., Sinkey C.A., Barenz T.A., and Haynes W.G. Effects of aging and atherosclerosis on endothelial and vascular smooth muscle function in humans. Int. J. Cardiol. 109 (2006) 201-206
3. Alvarez de Sotomayor M., Mingorance C., and Andriantsitohaina R. Fenofibrate improves age-related endothelial dysfunction in rat resistance arteries. Atherosclerosis 193 (2007) 112-120
4. Alvarez de Sotomayor M., Stoclet J.C., and Andriantsiohaina R. Effect of ageing on the endothelium-dependent vasorelaxation induced by acetylcholine in rat mesenteric arteries. In: Vanhoutte P.M. (Ed). Endothelium-derived Hyperpolarizations (1999), Harwood Academic Publishers, Amsterdam 323-332
5. Arenas I.A., Xu Y., and Davidge S.T. Age-associated impairment in vasorelaxation to fluid shear stress in the female vasculature is improved by TNF-α antagonism. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H1259-H1263
6. Arking D.E., Becker D.M., Yanek L.R., Fallin D., Judge D.P., Moy T.F., Becker L.C., and Dietz H.C. KLOTHO allele status and the risk of early-onset occult coronary artery disease. Am. J. Hum. Genet. 72 (2003) 1154-1161
7. Arking D.E., Krebsova A., Macek Sr. M., Macek Jr. M., Arking A., Mian I.S., Fried L., Hamosh A., Dey S., McIntosh I., and Dietz H.C. Association of human aging with a functional variant of klotho. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 856-861
8. Aviv H., Khan M.Y., Skurnick J., Okuda K., Kimura M., Gardner J., Priolo L., and Aviv A. Age dependent aneuploidy and telomere length of the human vascular endothelium. Atherosclerosis 159 (2001) 281-287
9. Ballard V.L., and Edelberg J.M. Targets for regulating angiogenesis in the ageing endothelium. Expert Opin. Ther. Targets 11 (2007) 1385-1399
10. Belmin J., Bernard C., Corman B., Merval R., Esposito B., and Tedgui A. Increased production of tumor necrosis factor and interleukin-6 by arterial wall of aged rats. Am. J. Physiol. 268 (1995) H2288-H2293
11. Ben-Porath I., and Weinberg R.A. When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest. 113 (2004) 8-13
12. Berkowitz D.E., White R., Li D., Minhas K.M., Cernetich A., Kim S., Burke S., Shoukas A.A., Nyhan D., Champion H.C., and Hare J.M. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108 (2003) 2000-2006
13. Blackwell K.A., Sorenson J.P., Richardson D.M., Smith L.A., Suda O., Nath K., and Katusic Z.S. Mechanisms of aging-induced impairment of endothelium-dependent relaxation: role of tetrahydrobiopterin. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H2448-H2453
14. Bode-Böger S.M., Muke J., Surdacki A., Brabant G., Böger R.H., and Frölich J.C. Oral l-arginine improves endothelial function in healthy individuals older than 70 years. Vasc. Med. 8 (2003) 77-81
15. Brandes R.P., Fleming I., and Busse R. Endothelial aging. Cardiovasc. Res. 6 (2005) 286-294
16. Breitschopf K., Zeiher A.M., and Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett. 493 (2001) 21-25
17. Briones A.M., Montoya N., Giraldo J., and Vila E. Ageing affects nitric oxide synthase, cyclooxygenase and oxidative stress enzymes expression differently in mesenteric resistance arteries. Auton. Autacoid. Pharmacol. 25 (2005) 155-162
18. Brown K.A., Chu Y., Lund D.D., Heistad D.D., and Faraci F.M. Gene transfer of extracellular superoxide dismutase protects against vascular dysfunction with aging. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H2600-H2605
19. Bruunsgaard H., Skinhoj P., Pedersen A.N., Schroll M., and Pedersen B.K. Ageing, tumour necrosis factor-α (TNF-α) and atherosclerosis. Clin. Exp. Immunol. 121 (2000) 255-260
20. Büssemaker E., Popp R., Fisslthaler B., Larson C.M., Fleming I., Busse R., and Brandes R.P. Aged spontaneously hypertensive rats exhibit a selective loss of EDHF-mediated relaxation in the renal artery. Hypertension 42 (2003) 562-568
21. Burnett A.L. The role of nitric oxide in erectile dysfunction: implications for medical therapy. J. Clin. Hypertens. (Greenwich) 8 Suppl. 4 (2006) 53-62
22. Campisi J. Cancer, aging and cellular senescence. In Vivo 14 (2000) 183-188
23. Cernadas M.R., Sánchez de Miguel L., García-Durán M., González-Fernández F., Millas I., Montón M., Rodrigo J., Rico L., Fernández P., de Frutos T., Rodriguez-Feo J.A., Guerra J., Caramelo C., Casado S., and Lopez-Farre A.J. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ. Res. 83 (1998) 279-286
24. Channon K.M. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Trends Cardiovasc. Med. 14 (2004) 323-327
25. Chung H.Y., Sung B., Jung K.J., Zou Y., and Yu B.P. The molecular inflammatory process in aging. Antioxid. Redox Signal. 8 (2006) 572-581
26. Coe C.L. Biological and social predictors of immune senescence in the aged primate. Mech. Ageing Dev. 125 (2004) 95-98
27. Coleman H.R., Chan C.C., Ferris III F.L., and Chew E.Y. Age-related macular degeneration. Lancet 372 (2008) 1835-1845
28. Cooke J.P. ADMA: its role in vascular disease. Vasc. Med. 10 Suppl. 1 (2005) S11-S17
29. Csiszar A., Labinskyy N., Orosz Z., and Ungvari Z. Altered mitochondrial energy metabolism may play a role in vascular aging. Med. Hypotheses 67 (2006) 904-908
30. Csiszar A., Labinskyy N., Smith K., Rivera A., Orosz Z., and Ungvari Z. Vasculoprotective effects of anti-tumor necrosis factor-α treatment in aging. Am. J. Pathol. 170 (2007) 388-398
31. Csiszar A., Pacher P., Kaley G., and Ungvari Z. Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. Curr. Vasc. Pharmacol. 3 (2005) 285-291
32. Csiszar A., Toth J., Peti-Peterdi J., and Ungvari Z. The aging kidney: role of endothelial oxidative stress and inflammation. Acta Physiol. Hung. 94 (2007) 107-115
33. Csiszar A., Ungvari Z., Edwards J.G., Kaminski P., Wolin M.S., Koller A., and Kaley G. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ. Res. 90 (2002) 1159-1166
34. Csiszar A., Ungvari Z., Koller A., Edwards J.G., and Kaley G. Aging induced proinflammatory shift in cytokine expression profile in rat coronary arteries. FASEB J. 17 (2003) 1183-1185
35. Csiszar A., Ungvari Z., Koller A., Edwards J.G., and Kaley G. Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging. Physiol. Genom. 17 (2004) 21-30
36. Csiszar A., Wang M., Lakatta E.G., and Ungvari Z. Inflammation and endothelial dysfunction during aging: role of NF-κB. J. Appl. Physiol. 105 (2008) 1333-1341
37. Davidge S.T., Hubel C.A., and McLaughlin M.K. Impairment of vascular function is associated with an age-related increase of lipid peroxidation in rats. Am. J. Physiol. 271 (1996) R1625-R1631
38. De Sotomayor M.A., Pérez-Guerrero C., Herrrera M.D., Jimenez L., Marín R., Marhuenda E., and Andriantsitohaina R. Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways. Br. J. Pharmacol. 146 (2005) 1130-1138
39. Delp M.D., Behnke B.J., Spier S.A., Wu G., and Muller-Delp J.M. Ageing diminishes endothelium-dependent vasodilatation and tetrahydrobiopterin content in rat skeletal muscle arterioles. J. Physiol. 586 (2008) 1161-1168
40. Di Massimo C., Scarpelli P., Di Lorenzo N., Caimi G., di Orio F., and Ciancarelli M.G. Impaired plasma nitric oxide availability and extracellular superoxide dismutase activity in healthy humans with advancing age. Life Sci. 78 (2006) 1163-1167
41. Donato A.J., Eskurza I., Silver A.E., Levy A.S., Pierce G.L., Gates P.E., and Seals D.R. Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ. Res. 100 (2007) 1659-1666
42. Donato A.J., Lesniewski L.A., and Delp M.D. The effects of aging and exercise training on endothelin-1 vasoconstrictor responses in rat skeletal muscle arterioles. Cardiovasc. Res. 66 (2005) 393-401
43. Erusalimsky J.D., and Skene C. Mechanisms of endothelial senescence. Exp. Physiol. 94 (2009) 299-304
44. Eskurza I., Myerburgh L.A., Kahn Z.D., and Seals D.R. Tetrahydrobiopterin augments endothelium-dependent dilatation in sedentary but not in habitually exercising older adults. J. Physiol. 568 (2005) 1057-1065
45. Ferrari A.U., Radaelli A., and Centola M. Invited review: aging and the cardiovascular system. J. Appl. Physiol. 95 (2003) 2591-2597
46. Förstermann U. Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol. Chem. 387 (2006) 1521-1533
47. Fukai T. Extracellular SOD and aged blood vessels. Am. J. Physiol. Heart Circ. Physiol. 297 (2009) H10-H12
48. Gates P.E., Boucher M.L., Silver A.E., Monahan K.D., and Seals D.R. Impaired flow-mediated dilation with age is not explained by l-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression. J. Appl. Physiol. 102 (2007) 63-71
49. Gaubert M.L., Sigaudo-Roussel D., Tartas M., Berrut G., Saumet J.L., and Fromy B. Endothelium-derived hyperpolarizing factor as an in vivo back-up mechanism in the cutaneous microcirculation in old mice. J. Physiol. 585 (2007) 617-626
50. Gloire G., Legrand-Poels S., and Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72 (2006) 1493-1505
51. Goettsch W., Lattmann T., Amann K., Szibor M., Morawietz H., Munter K., Muller S.P., Shaw S., and Barton M. Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis. Biochem. Biophys. Res. Commun. 280 (2001) 908-913
52. Goto K., Fujii K., Onaka U., Abe I., and Fujishima M. Angiotensin-converting enzyme inhibitor prevents age-related endothelial dysfunction. Hypertension 36 (2000) 581-587
53. Haendeler J., Hoffmann J., Brandes R.P., Zeiher A.M., and Dimmeler S. Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol. Cell. Biol. 23 (2003) 4598-4610
54. Hamilton C.A., Brosnan M.J., McIntyre M., Graham D., and Dominiczak A.F. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 37 (2000) 529-534
55. Haruna Y., Kashihara N., Satoh M., Tomita N., Namikoshi T., Sasaki T., Fujimori T., Xie P., and Kanwar Y.S. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 2331-2336
56. Hayashi T., Matsui-Hirai H., Miyazaki-Akita A., Fukatsu A., Funami J., Ding Q.F., Kamalanathan S., Hattori Y., Ignarro L.J., and Iguchi A. Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 17018-17023
57. Hayashi T., Yano K., Matsui-Hirai H., Yokoo H., Hattori Y., and Iguchi A. Nitric oxide and endothelial cellular senescence. Pharmacol. Ther. 120 (2008) 333-339
58. Heymes C., Habib A., Yang D., Mathieu E., Marotte F., Samuel J., and Boulanger C.M. Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in ageing. Br. J. Pharmacol. 131 (2000) 804-810
59. Higashi Y., Sasaki S., Nakagawa K., Kimura M., Noma K., Hara K., Jitsuiki D., Goto C., Oshima T., Chayama K., and Yoshizumi M. Tetrahydrobiopterin improves aging-related impairment of endothelium-dependent vasodilation through increase in nitric oxide production. Atherosclerosis 186 (2006) 390-395
60. Holowatz L.A., Thompson C.S., and Kenney W.L. l-Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin. J. Physiol. 574 (2006) 573-581
61. Ikushima M., Rakugi H., Ishikawa K., Maekawa Y., Yamamoto K., Ohta J., Chihara Y., Kida I., and Ogihara T. Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells. Biochem. Biophys. Res. Commun. 339 (2006) 827-832
62. Jaimes J.A., Zhou M.S., Pearse D.D., Puzis L., and Raij L. Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species. Am. J. Physiol. Renal Physiol. 294 (2008) F385-F392
63. Kansui Y., Fujii K., Goto K., Abe I., and Iida M. Angiotensin II receptor antagonist improves age-related endothelial dysfunction. J. Hypertens. 20 (2002) 439-446
64. Kielstein J.T., Bode-Böger S.M., Frölich J.C., Ritz E., Haller H., and Fliser D. Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 107 (2003) 1891-1895
65. Kim H.J., Kim K.S., Kim S.H., Baek S.H., Kim H.Y., Lee C., and Kim J.R. Induction of cellular senescence by secretory phospholipase A2 in human dermal fibroblasts through an ROS-mediated p53 pathway. J. Gerontol. A Biol. Sci. Med. Sci. 64 (2009) 351-362
66. Koh N., Fujimori T., Nishiguchi S., Tamori A., Shiomi S., Nakatani T., Sugimura K., Kishimoto T., Kinoshita S., Kuroki T., and Nabeshima Y. Severely reduced production of klotho in human chronic renal failure kidney. Biochem. Biophys. Res. Commun. 280 (2001) 1015-1020
67. Kunieda T., Minamino T., Miura K., Katsuno T., Tateno K., Miyauchi H., Kaneko S., Bradfield C.A., FitzGerald G.A., and Komuro I. Reduced nitric oxide causes age-associated impairment of circadian rhythmicity. Circ. Res. 102 (2008) 607-614
68. Kuro-o M. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr. Opin. Nephrol. Hypertens. 15 (2006) 437-441
69. Kuro-o M., in press. Klotho and aging. Biochim. Biophys. Acta. (available online).
70. Kuro-o M., Matsumura Y., Aizawa H., Kawaguchi H., Suga T., Utsugi T., Ohyama Y., Kurabayashi M., Kaname T., Kume E., Iwasaki H., Iida A., Shiraki-Iida T., Nishikawa S., Nagai R., and Nabeshima Y.I. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390 (1997) 45-51
71. Kurosu H., and Kuro-o M. The Klotho gene family as a regulator of endocrine fibroblast growth factors. Mol. Cell. Endocrinol. 299 (2009) 72-78
72. Kurosu H., Yamamoto M., Clark J.D., Pastor J.V., Nandi A., Gurnani P., McGuinness O.P., Chikuda H., Yamaguchi M., Kawaguchi H., Shimomura I., Takayama Y., Herz J., Kahn C.R., Rosenblatt K.P., and Kuro-o M. Suppression of aging in mice by the hormone Klotho. Science 309 (2005) 1829-1833
73. Kurz D.J., Hong Y., Trivier E., Huang H.L., Decary S., Zang G.H., Lüscher T.F., and Erusalimsky J.D. Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 748-754
74. Labinskyy N., Csiszar A., Veress G., Stef G., Pacher P., Oroszi G., Wu J., and Ungvari Z. Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen. Curr. Med. Chem. 13 (2006) 989-996
75. Lakatta E.G., and Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. I. Aging arteries: a "set up" for vascular disease. Circulation 107 (2003) 139-146
76. Laursen J.B., Somers M., Kurz S., McCann L., Warnholtz A., Freeman B.A., Tarpey M., Fukai T., and Harrison D.G. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103 (2001) 1282-1288
77. Long D.A., Newaz M.A., Prabhakar S.S., Price K.L., Truong L.D., Feng L., Mu W., Oyekan A.O., and Johnson R.J. Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging. Kidney Int. 68 (2005) 2154-2163
78. Lundberg M.S., and Crow M.T. Age-related changes in the signaling and function of vascular smooth muscle cells. Exp. Gerontol. 34 (1999) 549-557
79. Madamanchi N.R., and Runge M.S. Mitochondrial dysfunction in atherosclerosis. Circ. Res. 100 (2007) 460-473
80. Maeda S., Tanabe T., Miyauchi T., Otsuki T., Sugawara J., Iemitsu M., Kuno S., Ajisaka R., Yamaguchi I., and Matsuda M. Aerobic exercise training reduces plasma endothelin-1 concentration in older women. J. Appl. Physiol. 95 (2003) 336-341
81. Maekawa Y., Ishikawa K., Yasuda O., Oguro R., Hanasaki H., Kida I., Takemura Y., Ohishi M., Katsuya T., and Rakugi H. Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activation. Endocrine 35 (2009) 341-346
82. Mantelli L., Amerini S., and Ledda F. Roles of nitric oxide and endothelium-derived hyperpolarizing factor in vasorelaxant effect of acetylcholine as influenced by aging and hypertension. J. Cardiovasc. Pharmacol. 25 (1995) 595-602
83. Matsushita H., Chang E., Glassford A.J., Cooke J.P., Chiu C.P., and Tsao P.S. e NOS activity is reduced in senescent human endothelial cells: preservation by hTERT immortalization. Circ. Res. 89 (2001) 793-798
84. Matz R.L., and Andriantsitohaina R. Age-related endothelial dysfunction: potential implications for pharmacotherapy. Drugs Aging 20 (2003) 527-550
85. Matz R.L., de Sotomayor M.A., Schott C., Stoclet J.C., and Andriantsitohaina R. Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br. J. Pharmacol. 131 (2000) 303-311
86. Matz R.L., Schott C., Stoclet J.C., and Andriantsitohaina R. Age-related endothelial dysfunction with respect to NO, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol. Res. 49 (2000) 11-18
87. Medici D., Razzaque M.S., Deluca S., Rector T.L., Hou B., Kang K., Goetz R., Mohammadi M., Kuro O.M., Olsen B.R., and Lanske B. FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. J. Cell Biol. 182 (2008) 459-465
88. Minamino T., and Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ. Res. 100 (2007) 15-26
89. Mukai Y., Shimokawa H., Higashi M., Morikawa K., Matoba T., Hiroki J., Kunihiro I., Talukder H.M., and Takeshita A. Inhibition of renin-angiotensin system ameliorates endothelial dysfunction associated with aging in rats. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1445-1450
90. Mullin B.H., Wilson S.G., Islam F.M., Calautti M., Dick I.M., Devine A., and Prince R.L. Klotho gene polymorphisms are associated with osteocalcin levels but not bone density of aged postmenopausal women. Calcif. Tissue Int. 77 (2005) 145-151
91. Nakatani T., Sarraj B., Ohnishi M., Densmore M.J., Taguchi T., Goetz R., Mohammadi M., Lanske B., and Razzaque M.S. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23)-mediated regulation of systemic phosphate homeostasis. FASEB J. 23 (2009) 433-441
92. Neubert K., Haberland A., Kruse I., Wirth M., and Schimke I. The ratio of formation of prostacyclin/thromboxane A2 in HUVEC decreased in each subsequent passage. Prostaglandins 54 (1997) 447-462
93. Newaz M.A., Yousefipour Z., and Oyekan A. Oxidative stress-associated vascular aging is xanthine oxidase-dependent but not NAD(P)H oxidase-dependent. J. Cardiovasc. Pharmacol. 48 (2006) 88-94
94. Ogami M., Ikura Y., Ohsawa M., Matsuo T., Kayo S., Yoshimi N., Hai E., Shirai N., Ehara S., Komatsu R., Naruko T., and Ueda M. Telomere shortening in human coronary artery diseases. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 546-550
95. Outdo A., Martin C., Busseuil D., Vergely C., Demaison L., and Rochette L. NADPH oxidases are in part responsible for increased cardiovascular superoxide production during aging. Free Radic. Biol. Med. 40 (2006) 2214-2222
96. Pacher P., Mabley J.G., Soriano F.G., Liaudet L., Komjáti K., and Szabó C. Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation. Br. J. Pharmacol. 135 (2002) 1347-1350
97. Price J.M., Hellermann A., Hellermann G., and Sutton E.T. Aging enhances vascular dysfunction induced by the Alzheimer's peptide beta-amyloid. Neurol. Res. 26 (2004) 305-311
98. Pu D.R., and Liu L. HDL slowing down endothelial progenitor cells senescence: a novel anti-atherogenic property of HDL. Med. Hypotheses 70 (2008) 338-342
99. Radovits T., Seres L., Gero D., Berger I., Szabó C., Karck M., and Szabó G. Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction. Exp. Gerontol. 42 (2007) 676-685
100. Radovits T., Seres L., Gero D., Lin L.N., Beller C.J., Chen S.H., Zotkina J., Berger I., Groves J.T., Szabó C., and Szabó G. The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction. Mech. Ageing Dev. 128 (2007) 173-181
101. Rakugi H., Matsukawa N., Ishikawa K., Yang J., Imai M., Ikushima M., Maekawa Y., Kida I., Miyazaki J., and Ogihara T. Anti-oxidative effect of Klotho on endothelial cells through cAMP activation. Endocrine 31 (2007) 82-87
102. Razzaque M.S., Sitara D., Taguchi T., St-Arnaud R., and Lanske B. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J. 20 (2006) 720-722
103. Romero M.J., Platt D.H., Tawfik H.E., Labazi M., El-Remessy A.B., Bartoli M., Caldwell R.B., and Caldwell R.W. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ. Res. 102 (2008) 95-102
104. Ryoo S., Gupta G., Benjo A., Lim H.K., Camara A., Sikka G., Lim H.K., Sohi J., Santhanam L., Soucy K., Tuday E., Baraban E., Ilies M., Gerstenblith G., Nyhan D., Shoukas A., Christianson D.W., Alp N.J., Champion H.C., Huso D., and Berkowitz D.E. Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ. Res. 102 (2008) 923-932
105. Saito Y., Nakamura T., Ohyama Y., Suzuki T., Iida A., Shiraki-Iida T., Kuro-o M., Nabeshima Y., Kurabayashi M., and Nagai R. In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem. Biophys. Res. Commun. 276 (2000) 767-772
106. Saito Y., Yamagishi T., Nakamura T., Ohyama Y., Aizawa H., Suga T., Matsumura Y., Masuda H., Kurabayashi M., Kuro-o M., Nabeshima Y., and Nagai R. Klotho protein protects against endothelial dysfunction. Biochem. Biophys. Res. Commun. 248 (1998) 324-329
107. Sanada M., Taguchi A., Higashi Y., Tsuda M., Kodama I., Yoshizumi M., and Ohama K. Forearm endothelial function and bone mineral loss in postmenopausal women. Atherosclerosis 176 (2004) 387-392
108. Santhanam L., Christianson D.W., Nyhan D., and Berkowitz D.E. Arginase and vascular aging. J. Appl. Physiol. 105 (2008) 1632-1642
109. Santhanam L., Lim H.K., Lim H.K., Miriel V., Brown T., Patel M., Balanson S., Ryoo S., Anderson M., Irani K., Khanday F., Di Costanzo L., Nyhan D., Hare J.M., Christianson D.W., Rivers R., Shoukas A., and Berkowitz D.E. Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ. Res. 101 (2007) 692-702
110. Scheubel R.J., Zorn H., Silber R.E., Kuss O., Morawietz H., Holtz J., and Simm A. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J. Am. Coll. Cardiol. 42 (2003) 2073-2080
111. Serrano A.L., and Andrés V. Telomeres and cardiovascular disease: does size matter?. Circ. Res. 94 (2004) 575-584
112. Shimada T., Takeshita Y., Murohara T., Sasaki K., Egami K., Shintani S., Katsuda Y., Ikeda H., Nabeshima Y., and Imaizumi T. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 110 (2004) 1148-1155
113. Shimada Y., Ito H., Kaji K., and Fukuda M. Tumor necrosis factor reduces lifespan of human endothelial cells in vitro. Mech. Ageing Dev. 55 (1990) 245-254
114. Shimokawa H., Yasutake H., Fujii K., Owada M.K., Nakaike R., Fukumoto Y., Takayanagi T., Nagao T., Egashira K., Fujishima M., and Takeshita A. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J. Cardiovasc. Pharmacol. 28 (1996) 703-711
115. Sindler, A.L., Delp, M.D., Reyes, R., Wu, G., Muller-Delp, J.M., in press. Effects of aging and exercise training on eNOS uncoupling in skeletal muscle resistance arterioles. J. Physiol. (available online).
116. Smith A.R., Visioli F., and Hagen T.M. Plasma membrane-associated endothelial nitric oxide synthase and activity in aging rat aortic vascular endothelia markedly decline with age. Arch. Biochem. Biophys. 454 (2006) 100-105
117. Soucy K.G., Ryoo S., Benjo A., Lim H.K., Gupta G., Sohi J.S., Elser J., Aon M.A., Nyhan D., Shoukas A.A., and Berkowitz D.E. Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiffness. J. Appl. Physiol. 101 (2006) 1751-1759
118. Spier S.A., Delp M.D., Meininger C.J., Donato A.J., Ramsey M.W., and Muller-Delp J.M. Effects of ageing and exercise training on endothelium-dependent vasodilatation and structure of rat skeletal muscle arterioles. J. Physiol. 556 (2004) 947-958
119. Stauffer B.L., Westby C.M., and DeSouza C.A. Endothelin-1, aging and hypertension. Curr. Opin. Cardiol. 23 (2008) 350-355
120. Sung B., Park S., Yu B.P., and Chung H.Y. Amelioration of age-related inflammation and oxidative stress by PPARgamma activator: suppression of NF-kappaB by 2,4-thiazolidinedione. Exp. Gerontol. 41 (2006) 590-599
121. Tang E.H., and Vanhoutte P.M. Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension. Physiol. Genom. 32 (2008) 409-418
122. Tatar M., Bartke A., and Antebi A. The endocrine regulation of aging by insulin-like signals. Science 299 (2003) 1346-1351
123. Thum T., Hoeber S., Froese S., Klink I., Stichtenoth D.O., Galuppo P., Jakob M., Tsikas D., Anker S.D., Poole-Wilson P.A., Borlak J., Ertl G., and Bauersachs J. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ. Res. 100 (2007) 434-443
124. Toro L., Marijic J., Nishimaru K., Tanaka Y., Song M., and Stefani E. Aging, ion channel expression, and vascular function. Vascul. Pharmacol. 38 (2002) 73-80
125. Toussaint O., Royer V., Salmon M., and Remacle J. Stress-induced premature senescence and tissue ageing. Biochem. Pharmacol. 64 (2002) 1007-1009
126. Toussaint O., Medrano E.E., and von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp. Gerontol. 35 (2000) 927-945
127. Trivier E., Kurz D.J., Hong Y., Huang H.L., and Erusalimsky J.D. Differential regulation of telomerase in endothelial cells by fibroblast growth factor-2 and vascular endothelial growth factor-a: association with replicative life span. Ann. N.Y. Acad. Sci. 1019 (2004) 111-115
128. Ungvari Z., Csiszar A., and Kaley G. Vascular inflammation in aging. Herz 29 (2004) 733-740
129. 2 production promotes endothelial NF-kB activation in aged rat arteries. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H37-H47
130. Utsugi T., Ohno T., Ohyama Y., Uchiyama T., Saito Y., Matsumura Y., Aizawa H., Itoh H., Kurabayashi M., Kawazu S., Tomono S., Oka Y., Suga T., Kuro-o M., Nabeshima Y., and Nagai R. Decreased insulin production and increased insulin sensitivity in the klotho mutant mouse, a novel animal model for human aging. Metabolism 49 (2000) 1118-1123
131. Van der Loo B., Labugger R., Skepper J.N., Bachschmid M., Kilo J., Powell J.M., Palacios-Callender M., Erusalimsky J.D., Quaschning T., Malinski T., Gygi D., Ullrich V., and Lüscher T.F. Enhanced peroxynitrite formation is associated with vascular aging. J. Exp. Med. 192 (2000) 1731-1744
132. Van Guilder G.P., Westby C.M., Greiner J.J., Stauffer B.L., and De Souza C.A. Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension 50 (2007) 403-409
133. Vanhoutte P.M. Endothelial dysfunction. Circ. J. 73 (2009) 595-601
134. Vanhoutte P.M., and Tang E.H.C. Endothelium-dependent contractions: when a good guy turns bad. J. Physiol. 586 (2008) 5295-5304
135. Vasa M., Breitschopf K., Zeiher A.M., and Dimmeler S. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ. Res. 87 (2000) 540-542
136. Vásquez-Vivar J., Kalyanaraman B., and Martásek P. The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free Radic. Res. 37 (2003) 121-127
137. Wallace S.M., Yasmin, McEniery C.M., Mäki-Petäjä K.M., Booth A.D., Cockcroft J.R., and Wilkinson I.B. Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension 50 (2007) 228-233
138. Wang Y., and Sun Z. Current understanding of klotho. Ageing Res. Rev. 8 (2009) 43-51
139. Weinsaft J.W., and Edelberg J.M. Aging-associated changes in vascular activity: a potential link to geriatric cardiovascular disease. Am. J. Geriatr. Cardiol. 10 (2001) 348-354
140. White A.R., Ryoo S., Li D., Champion H.C., Steppan J., Wang D., Nyhan D., Shoukas A.A., Hare J.M., and Berkowitz D.E. Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension 47 (2006) 245-251
141. Wu S., Ruan Y., Yin M., and Lai W. Research on the age-related changes in the nitric oxide pathway in the arteries of rats and the intervention effect of dehydroepiandrosterone. Gerontology 53 (2007) 234-237
142. Xia Y., Dawson V.L., Dawson T.M., Snyder S.H., and Zweier J.L. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 6770-6774
143. Xia Y., and Zweier J.L. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6954-6958
144. Xin M.G., Zhang J., Block E.R., and Patel J.M. Senescence-enhanced oxidative stress is associated with deficiency of mitochondrial cytochrome c oxidase in vascular endothelial cells. Mech. Ageing Dev. 124 (2003) 911-919
145. Xiong Y., Yuan L.W., Deng H.W., Li Y.J., and Chen B.M. Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats. Clin. Exp. Pharmacol. Physiol. 28 (2001) 842-847
146. Yang J., Chang E., Cherry A.M., Bangs C.D., Oei Y., Bodnar A., Bronstein A., Chiu C.P., and Herron G.S. Human endothelial cell life extension by telomerase expression. J. Biol. Chem. 274 (1999) 26141-26148
147. Yildiz O. Vascular smooth muscle and endothelial functions in aging. Ann. N.Y. Acad. Sci. 1100 (2007) 353-360
148. Yoshida Y.I., Eda S., and Masada M. Alterations of tetrahydrobiopterin biosynthesis and pteridine levels in mouse tissues during growth and aging. Brain Dev. 22 Suppl. 1 (2000) S45-S49
149. Zaccagnini G., Gaetano C., Della Pietra L., Nanni S., Grasselli A., Mangoni A., Benvenuto R., Fabrizi M., Truffa S., Germani A., Moretti F., Pontecorvi A., Sacchi A., Bacchetti S., Capogrossi M.C., and Farsetti A. Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia. J. Biol. Chem. 280 (2005) 14790-14798
150. Zhang H., Park Y., Wu J., Chen X., Lee S., Yang J., Dellsperger K.C., and Zhang C. Role of TNF-α in vascular dysfunction. Clin. Sci. 116 (2009) 219-230